Formononetin improves heart failure with preserved ejection fraction in mice by activating the PPARα/PGC-1 pathwayOA
Formononetin improves heart failure with preserved ejection fraction in mice by activating the PPARα/PGC-1 pathway
Hang Xu;Xiaoqian Zhang;Liming Huang;Fei Li;Yiyuan Tian;Chao Guo;Yi Ding;Jing Ma;Chao Liu
Department of Traditional Chinese Medicine,Xijing Hospital,Fourth Military Medical University,Xi'an 710032,ChinaDepartment of Neonatology,the Second Affiliated Hospital of Shaanxi University of Chinese Medicine,Xianyang 712000,ChinaDepartment of Pharmacy,986 Hospital of People's Liberation Army Air Force,Xi'an 710032,ChinaDepartment of Cardiology,Xijing Hospital,Fourth Military Medical University,Xi'an 710032,ChinaDepartment of Cardiology,Xijing Hospital,Fourth Military Medical University,Xi'an 710032,ChinaDepartment of Pharmacy,Xijing Hospital,Fourth Military Medical University,Xi'an 710032,ChinaDepartment of Pharmacy,Xijing Hospital,Fourth Military Medical University,Xi'an 710032,ChinaDepartment of Traditional Chinese Medicine,Xijing Hospital,Fourth Military Medical University,Xi'an 710032,ChinaDepartment of Cardiology,Xijing Hospital,Fourth Military Medical University,Xi'an 710032,China
formononetinheart failure with preserved ejection fractionPPARαPPARα/PGC-1 pathwayenergy metabolism
formononetinheart failure with preserved ejection fractionPPARαPPARα/PGC-1 pathwayenergy metabolism
《传统医学研究(英文版)》 2024 (4)
12-19,8
This work was supported by the National Natural Science Foundation of China(82274313),Key R&D Program of Shaanxi Province(2023GHZD43),and the National Natural Science Foundation of China(81870284).
评论